Drugs / RG6341
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05660850 | Mar 2023 → Oct 2024 | chronic asthma, chronic bronchitis | Genentech, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RG6341 | ChEMBL registry synonym — accepted as the source's own label CHEMBL5940975 ↗ |
| Known as | GDC-6599 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05660850 ↗ |
| Modality | Small molecule | — CHEMBL5940975 ↗ |